Enorama Pharma AB is a Swedish pharmaceutical company based in Malmö, Sweden, with a fully owned subsidiary in Florida, USA. Listed on Nasdaq First North Growth Market in Stockholm since 2016, Enorama Pharma is focusing on the development, manufacturing, and sales of consumer-friendly, oral nicotine products, such as nicotine white pouches under the brand name NIC-S® and medicinal, nicotine chewing gums.

Our values

Offering the opportunity to reduce, and eventually eliminate, individual tobacco use is our core value and the momentum for all parts of the company.